Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)Active Not Recruiting
Sponsor: AstraZeneca
Non Small Cell Lung Carcinoma NSCLC
United States, Argentina, Brazil, Bulgaria, Chile +24 more
Sponsor: Eli Lilly and Company
Lymphoma, Non-Hodgkin's · Lymphoma, Diffuse Large B-Cell · Follicular Lymphoma
United States, France, Germany, Italy, Japan +3 more
Sponsor: Ferring Pharmaceuticals
Intermediate Risk Non-Muscle Invasive Bladder Cancer
United States, Canada, Czechia, Denmark, France +4 more
Sponsor: AstraZeneca
Relapsed Refractory Multiple Myeloma
United States, Australia, Brazil, Canada, China +10 more
Sponsor: Incyte Corporation
Ovarian Cancer
United States, Australia, Belgium, Japan, Puerto Rico +3 more
Sponsor: Boehringer Ingelheim
Obesity · Diabetes Mellitus, Type 2
United States, Australia, Belgium, Canada, China +14 more
- Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)Active Not Recruiting
Sponsor: AstraZeneca
Non-Small-Cell Lung Carcinoma NSCLC
United States, Australia, Belgium, Canada, France +12 more
Sponsor: Eli Lilly and Company
Atherosclerosis Cardiovascular Disease · Chronic Kidney Disease
Argentina, Australia, Austria, Belgium, Brazil +33 more
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Brazil, Canada, China +8 more
Sponsor: Sanofi
Chronic Spontaneous Urticaria
Argentina, Canada, Chile, Germany, Greece +8 more
Sponsor: Merck Sharp & Dohme LLC
Hypercholesterolemia · Familial Hypercholesterolemia
United States, Argentina, China, Colombia, Germany +9 more
Sponsor: Hoffmann-La Roche
Hemophilia A
United States, Belgium, China, France, Germany +10 more
Sponsor: Incyte Corporation
CRC (Colorectal Cancer)
United States, Argentina, Australia, Austria, Belgium +16 more
Sponsor: Incyte Corporation
Essential Thrombocythemia
United States, Australia, Austria, Belgium, Canada +13 more
- Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)Active Not Recruiting
Sponsor: Sanofi
Dermatitis Atopic
Argentina, Australia, Austria, Belgium, Colombia +17 more
- A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic CarcinomasNot Yet Recruiting
Sponsor: National Cancer Center, Japan
Unresectable Thymic Carcinoma
Japan
- Specified Drug-use Survey of Leqvio for s.c. Injection.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Familial Hypercholesterolaemia · Hypercholesterolaemia
Japan
- Diagnostic Value of EBUS-Guided Transbronchial Mediastinal Cryobiopsy Versus Conventional Bronchoscopic Approaches for Stage I/II SarcoidosisActive Not Recruiting
Sponsor: China-Japan Friendship Hospital
Sarcoidosis, Pulmonary
China
Sponsor: Boehringer Ingelheim
Metastatic Breast Cancer · Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Esophageal Adenocarcinoma
United States, Belgium, China, France, Germany +5 more
Sponsor: Incyte Corporation
Ovarian Cancer
United States, Australia, Belgium, Canada, France +11 more
Sponsor: Eli Lilly and Company
Depressive Disorder, Major
United States, Australia, Brazil, Canada, China +10 more
Sponsor: Revolution Medicines, Inc.
NSCLC (Non-small Cell Lung Cancer) · Non-Small Cell Lung Cancer · NSCLC · NSCLC (Non-small Cell Lung Carcinoma)
United States, Australia, Belgium, France, Germany +14 more
Sponsor: Eli Lilly and Company
Sleep Apnea, Obstructive · Obesity · Overweight
United States, Australia, Brazil, Canada, China +6 more
Sponsor: Eli Lilly and Company
Irritable Bowel Syndrome · Constipation
United States, Belgium, Canada, China, Japan +3 more
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)Recruiting
Sponsor: Eli Lilly and Company
Irritable Bowel Syndrome · Diarrhea
United States, Belgium, Canada, China, Germany +5 more